Caris Life Sciences is now Miraca Life Sciences

Since 2005, Caris Life Sciences has established an unprecedented reputation among clinicians by creating an innovative, best-in-class practice that results in improved patient care. The word “Miraca” is a combination of the Japanese words “future” and “science,” so the new corporate name is a natural fit for the company’s mission and Miraca’s global network of employees, clinicians, and patients.

“The new name is a logical step as we complete the successful ownership transition of this world-class diagnostics organization,” said Takeo Hayashi, Chairman and CEO of the newlynamed Miraca Life Sciences. “While the name has changed, the fundamental value proposition has not: a unique, high quality pathology practice with an abiding commitment to diagnostic excellence and improved patient care.”